Characterization of rat and mouse NAD⁺-dependent 3α/17β/20α-hydroxysteroid dehydrogenases and identification of substrate specificity determinants by site-directed mutagen

详细信息	查看全文 | 推荐本文 |

• 作者：Satoshi Endo ; Masaharu Sanai ; Kenji Horie ; Toshiyuki Matsunaga ; Shuhei Ishikura ; Kazuo Tajima ; Ossama El-Kabbani ; Akira Hara
• 关键词：Aldo-keto reductase superfamily ; 3α ; -Hydroxysteroid dehydrogenase ; 3α ; /17β ; /20α ; -Hydroxysteroid dehydrogenase ; Steroid specificity ; Site-directed mutagenesis
• 刊名：Archives of Biochemistry and Biophysics
• 出版年：2007
• 期刊代码：116_00039861
• 类别：ch
• 出版时间：1 November 2007
• 卷：467
• 期：1
• 页码：76-86
• 文件大小：733 K

摘要

In this study, we characterized rat and mouse aldo-keto reductases (AKR1C16 and AKR1C13, respectively) with 92%sequence identity. The recombinant enzymes oxidized non-steroidal alcohols using NAD⁺ as the preferred coenzyme, and showed low 3α/17β/20α-hydroxysteroid dehydrogenase (HSD) activities. The substrate specificity differs from that of rat NAD⁺-dependent 3α-HSD (AKR1C17) that shares 95%sequence identity with AKR1C16. To elucidate the residues determining the substrate specificity of the enzymes, we performed site-directed mutagenesis of Tyr24, Asp128 and Phe129 of AKR1C16 with the corresponding residues (Ser, Tyr and Leu, respectively) of AKR1C17. The double mutation (Asp128/Tyr-Phe129/Leu) had few effects on the substrate specificity, while the Tyr24/Ser mutant showed only 3α-HSD activity, and the triple mutation of the three residues produced an enzyme that had almost the same properties as AKR1C17. The importance of the residue 24 for substrate recognition was verified by the mutagenesis of Ser24/Tyr of AKR1C17 which resulted in a decrease in 3α-HSD activity and appearance of 17β- and 20α-HSD activities. AKR1C16 is also 92%identical with rat NAD⁺-dependent 17β-HSD (AKR1C24), which possesses Tyr24. The replacement of Asp128, Phe129 and Ser137 of AKR1C16 with the corresponding residues (Glu, Ser and Phe, respectively) of AKR1C24 increased the catalytic efficiency for 17β- and 20α-hydroxysteroids.